Very similar exposure is realized with subcutaneous administration of semaglutide from the abdomen, thigh, or upper arm. All GLP-one agonist medicines are administered subcutaneously (into your fatty tissue under the pores and skin) in one of these spots: This side outcome may well reduce or disappear with continued use with the drug. If it d